← All FR Documents ·← Back to 2025-01478
Notice

Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey

📖 Research Context From Federal Register API

Key Dates
Citation: 89 FR 78845
Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Commerce Department, Foreign-Trade Zones Board. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2024-22102
FR Citation89 FR 78845
TypeNotice
PublishedSep 26, 2024
Effective Date-
RIN-
Docket IDB-50-2024
Pages78845–78845 (1 pages)
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

Related Documents (by RIN/Docket)

Doc #TypeTitlePublished
2025-01478 Notice Foreign-Trade Zone (FTZ) 49; Authorizati... Jan 22, 2025

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (317 words · ~2 min read)

Text Preserved
<NOTICE> DEPARTMENT OF COMMERCE <SUBAGY>Foreign-Trade Zones Board</SUBAGY> <DEPDOC>[B-50-2024]</DEPDOC> <SUBJECT>Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey</SUBJECT> Merck, Sharp & Dohme LLC submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Rahway, New Jersey, within Subzone 49Y. The notification conforming to the requirements of the Board's regulations (15 CFR 400.22) was received on September 18, 2024. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board's website—accessible via <E T="03">www.trade.gov/ftz.</E> The proposed finished product and material/component would be added to the production authority that the Board previously approved for the operation, as reflected on the Board's website. The proposed finished product for research and development is MK-6878 HIV drug product (duty-free). The proposed foreign-status material/component is MK-6878 HIV active pharmaceutical ingredient (duty rate, 6.5%). The request indicates that this material/component is subject to duties under section 301 of the Trade Act of 1974 (section 301), depending on the country of origin. The applicable section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board's Executive Secretary and sent to: <E T="03">ftz@trade.gov.</E> The closing period for their receipt is November 5, 2024. A copy of the notification will be available for public inspection in the “Online FTZ Information System” section of the Board's website. For further information, contact Diane Finver at <E T="03">Diane.Finver@trade.gov.</E> <SIG> <DATED>Dated: September 23, 2024.</DATED> <NAME>Elizabeth Whiteman,</NAME> Executive Secretary. </SIG> <FRDOC>[FR Doc. 2024-22102 Filed 9-25-24; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.